177595-28-7

Basic information

• Product Name: 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride
• Synonyms: 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride;(4-(2H-Tetrazol-5-yl)phenyl)methanamine hydrochloride;4-(2H-TETRAZOL-5-YL)-BENZENEMETHANAMINE HCL
• CAS NO: 177595-28-7
• Molecular Formula: C₈H₉N₅*ClH
• Molecular Weight: 211.6515
• Mol File: 177595-28-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride(177595-28-7)
• EPA Substance Registry System: 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride(177595-28-7)

Safety Data

• Hazardous Substances Data: 177595-28-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride is used as a chemical intermediate for the synthesis of various pharmaceuticals and organic compounds. Its unique structure and properties make it a valuable component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Research Laboratories:
In research settings, 4-(2H-tetrazol-5-yl)-benzenemethanamine hydrochloride is utilized for a range of organic synthesis reactions. Its versatility and reactivity in chemical processes support the exploration of novel chemical entities and the optimization of existing compounds, furthering scientific understanding and innovation in organic chemistry.

Upstream product

• 66389-80-8 tert-butyl N-[(4-cyanophenyl)methyl]carbamate 
• 15996-76-6 4-cyanobenzylamine hydrochloride 

Downstream Products

• 177735-95-4 N-[4-(1H-5-tetrazolyl)phenylmethyl]-7-(2-quinolinylmethoxy)-2-naphthalenecarboxamide 

Relevant articles and documents

INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.

INDAZOLE DERIVATIVES

The invention is concerned with novel indazole derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, X and Y are as defined in the description and in the claims, as well as physiologic